| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 7 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Australia | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Animal care | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Greenfield Susan Adele | 10 |
| #2 | Vaux David John Talbutt | 5 |
| #3 | Rawlins John Nicholas Pepys | 4 |
| #4 | Deacon Robert Michael John | 4 |
| #5 | Westwell Martin | 3 |
| #6 | Voskuil Jan Louis Albert | 2 |
| #7 | Cottingham Matthew Guy | 2 |
| Publication | Filing date | Title |
|---|---|---|
| GB0308435D0 | Pharmaceutical formulation of apomorphine | |
| GB0221320D0 | Antibodies to biologically-active fragment of acetylcholinesterase | |
| AU4432901A | Alpha 7 nicotinic receptor screening assays | |
| WO0149107A1 | Animal models for neurodegenerative disease | |
| GB0030660D0 | Screening assays | |
| GB0028577D0 | Diagnostic Assays | |
| GB0028578D0 | Screening assays |